Job alerts from Alpine Immune Sciences, Inc.
Never miss new job openings
No, I'm not interested
bell icon

Alpine Immune Sciences was founded in 2015 by experts in the field of recombinant protein immunotherapies and a team responsible for the FDA's approval of the world's first cancer immunotherapy. We are headquartered in the heart of Seattle's beautiful waterfront. Alpine's platform is based on evolving naturally occurring immune system proteins. Using a process called "directed evolution" we modify proteins native to the immune synapse, improving them to be used as therapeutic agents for oncology, autoimmune/inflammatory disorders, and other diseases.

Company - Public
$5M to $10M
Small
Multiple locations
Scientific Research & Development Firms
2015